EMA grants first paediatric positive opinion to ViroPharma's midazolam
This article was originally published in Scrip
Executive Summary
The EU's CHMP has granted its first ever positive opinion for paediatric use marketing authorisation (PUMA) under the new Paediatric Regulation that came into force in 2007.